The Daily Papule

Monday 12 October

IJDLetter
Newly Recorded Cardiometabolic Diagnoses in Adolescents With Hidradenitis Suppurativa.
Islam RK, Islam KN, … senior author Haas CInternational Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Saturday 10 October

JEADVReview
The future management of HS
People with HS as partners.
Saunte DML, Christensen EMM, … senior author Jemec GBEJournal of the European Academy of Dermatology and Venereology
Read at publisher(opens in a new tab)

Friday 9 October

IJDLetter
Low-Dose Tumescent Triamcinolone-Clindamycin Mixture for Hidradenitis Suppurativa: A Case Series.
Nemeth K, Goldberg MInternational Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Thursday 8 October

Pediatr DermObservational study
Impact of Biologic Therapy on Emergency Department Utilization in Pediatric Hidradenitis Suppurativa Patients.
Kherallah K, Chung CS, … senior author Lee KHPediatric Dermatology
Read at publisher(opens in a new tab)

Tuesday 6 October

JAAD Int
Concomitant anti-tumor necrosis factor and anti-interleukin 17 therapy in severe, refractory hidradenitis suppurativa: A case series.
Bastian E, Bizuneh L, … senior author Naik HBJAAD International
No abstractRead at publisher(opens in a new tab)

Monday 5 October

Pediatr DermObservational study
Expanding Access to Care
Implementation of a Pediatric and Young Adult Laser Hair Removal Program for Hidradenitis Suppurativa.
Lee S, Servattalab S, Damji YPediatric Dermatology
Read at publisher(opens in a new tab)

Saturday 3 October

JEADVReview
Upcoming novel treatments for hidradenitis suppurativa
An overview of the pipeline.
Tzellos T, Liakou AI, … senior author Prignano FJournal of the European Academy of Dermatology and Venereology
Read at publisher(opens in a new tab)
JEADVObservational study
Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa
A nationwide cohort study.
Nielsen VW, Holgersen N, … senior author Thomsen SFJournal of the European Academy of Dermatology and Venereology
Read at publisher(opens in a new tab)
JEADVObservational studyLetter
Risk of arthritis in patients with hidradenitis suppurativa
A population-based cohort study.
Holgersen N, Pedersen NH, … senior author Thomsen SFJournal of the European Academy of Dermatology and Venereology
No abstractRead at publisher(opens in a new tab)

Thursday 1 October

JIDLaboratory research
A Long-term Subcutaneous Flap-Protected Xenograft Model of Hidradenitis Suppurativa Preserves Active Tunnel Progression and Immune Microenvironment.
Delliturri M, Chiu E, Lu CPJournal of Investigative Dermatology
No abstractRead at publisher(opens in a new tab)
Derm TherObservational study
Window of Opportunity and Predictors of Sustained Remission in Patients with Hidradenitis Suppurativa Treated with Adalimumab
A 540-Patient Cohort Study.
Vilarrasa E, Garbayo-Salmons P, … senior author Romaní JDermatology and Therapy
Read at publisher(opens in a new tab)
JEADVLaboratory researchLetter
Clinical and transcriptomic evidence for systemic neutrophil activation in hidradenitis suppurativa.
Moon S, Na H, … senior author Shin JUJournal of the European Academy of Dermatology and Venereology
No abstractRead at publisher(opens in a new tab)
JAADRCT
Sonelokimab, a novel IL-17A- and IL-17F-inhibiting nanobody for the treatment of moderate-to-severe hidradenitis suppurativa
a global, randomized, double-blind, placebo-controlled phase 2 clinical trial (MIRA).
Kimball AB, Bechara FG, … senior author Kirby BJournal of the American Academy of Dermatology
Read at publisher(opens in a new tab)

Wednesday 30 September

Skin Health DisObservational study
'My HS is significantly impacted by my cycle'
a cross-sectional study exploring the impact of menstruation and pregnancy on hidradenitis suppurativa.
Garrett O, Hutchison E, Wainman HESkin Health and Disease
Read at publisher(opens in a new tab)
JAADSystematic review
Certolizumab Pegol for Hidradenitis Suppurativa: A Systematic Review.
Abdul Ghafoor AA, Wen S, … senior author Piguet VJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
Skin Health DisMeta-analysisSystematic review
Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa
a systematic review and meta-analysis of randomized controlled trials.
Ishkirat H, Abarca-Pineda YA, … senior author Ayyan MSkin Health and Disease
Read at publisher(opens in a new tab)

Tuesday 29 September

Derm TherReview
Management Considerations for Patients with Hidradenitis Suppurativa and Lupus Spectrum Disease: A Narrative Review.
Chung CS, Kherallah K, … senior author Lee KHDermatology and Therapy
Read at publisher(opens in a new tab)
JEADVLetter
Clinical-metabolic phenotypes of hidradenitis suppurativa in a Chinese multicentre cohort.
Hasen A, Yang L, … senior author Li YJournal of the European Academy of Dermatology and Venereology
No abstractRead at publisher(opens in a new tab)
JEADVLetter
Mapping of perilesional inflammation in hidradenitis suppurativa
Evidence for 5-mm surgical margins.
Enault C, Vlaeminck-Guillem V, … senior author Guillem PJournal of the European Academy of Dermatology and Venereology
No abstractRead at publisher(opens in a new tab)

Monday 28 September

Arch Derm Res
Flare management perspectives among patients with hidradenitis suppurativa: a qualitative study
Baker NM, Santiago-Soltero K, … senior author Charrow APArchives of Dermatological Research
No abstractRead at publisher(opens in a new tab)

Journals and topics

Hidradenitis suppurativa

Monday 12 October

Newly Recorded Cardiometabolic Diagnoses in Adolescents With Hidradenitis Suppurativa.

Saturday 10 October

The future management of HS

Friday 9 October

Low-Dose Tumescent Triamcinolone-Clindamycin Mixture for Hidradenitis Suppurativa: A Case Series.

Thursday 8 October

Impact of Biologic Therapy on Emergency Department Utilization in Pediatric Hidradenitis Suppurativa Patients.

Tuesday 6 October

Concomitant anti-tumor necrosis factor and anti-interleukin 17 therapy in severe, refractory hidradenitis suppurativa: A case series.

Monday 5 October

Expanding Access to Care

Saturday 3 October

Upcoming novel treatments for hidradenitis suppurativa

Glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa

Risk of arthritis in patients with hidradenitis suppurativa

Thursday 1 October

A Long-term Subcutaneous Flap-Protected Xenograft Model of Hidradenitis Suppurativa Preserves Active Tunnel Progression and Immune Microenvironment.

Window of Opportunity and Predictors of Sustained Remission in Patients with Hidradenitis Suppurativa Treated with Adalimumab

Clinical and transcriptomic evidence for systemic neutrophil activation in hidradenitis suppurativa.

Sonelokimab, a novel IL-17A- and IL-17F-inhibiting nanobody for the treatment of moderate-to-severe hidradenitis suppurativa

Wednesday 30 September

'My HS is significantly impacted by my cycle'

Certolizumab Pegol for Hidradenitis Suppurativa: A Systematic Review.

Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa

Tuesday 29 September

Management Considerations for Patients with Hidradenitis Suppurativa and Lupus Spectrum Disease: A Narrative Review.

Clinical-metabolic phenotypes of hidradenitis suppurativa in a Chinese multicentre cohort.

Mapping of perilesional inflammation in hidradenitis suppurativa

Monday 28 September

Flare management perspectives among patients with hidradenitis suppurativa: a qualitative study